Atomo and NG Biotech expand COVID-19 partnership: Atomo secures exclusive rights for Australia, New Zealand and South East Asia[1]
SYDNEY, June 9, 2020 /PRNewswire/ -- Atomo Diagnostics Limited (ASX: AT1) (Atomo ) is pleased to announce it has expanded its existing COVID-19 rapid test partnership with NG Biotech, SAS (NG Biotech), which was announced to ASX on 14 April 2020 in Atomo's Second Supplementary Prospectus (Second S...
2020-06-09 08:02
1314
Atomo Diagnostics to list on ASX after successful IPO and virtual bell ringing ceremony
SYDNEY, April 16, 2020 /PRNewswire/ -- Following an oversubscribed initial public offering and the first ASX virtual bell ringing listing, trading of shares in Australian rapid blood test company Atomo Diagnostics Limited (Atomo) commenced on the Australian Securities Exchange (ASX) today under t...
2020-04-16 11:15
8770
